Home AI Medical Technology

AI Medical Technology

AI Medical Technology

AI Medical Technology
Category
Business Description
AI Medical Technology has developed the smartphone application Dermalyser, a clinically validated AI-powered medical software device for skin cancer diagnostic support. Dermalyser enables healthcare professionals to make fast and accurate diagnoses for their patients.
Long Business Description

Dermalyser is a smartphone application powered by artificial intelligence (AI) providing diagnostic decision support for medical professionals in clinical settings. Dermalyser enables fast and accurate diagnosis of melanoma, the most dangerous type of skin cancer. The application is used with a dermatoscope (magnifying glass) mounted in front of the smartphone camera. The medical professional takes an image of the patient’s suspicious skin lesion and, within a few seconds, receives a result from the AI. With Dermalyser, skin cancer can be diagnosed in time, and unnecessary surgeries can be avoided. Dermalyser can save patient lives while the standardised course of care for melanoma and healthcare becomes time and cost-efficient.

Based in
Stockholm
Tags
Medtech, Cancer diagnostics, AI
Total Funding
Between €1 million-€ 2.5 million
Founded
2021
Website
https://www.aimedtech.com/about
Company Status
Active

Articles about AI Medical Technology:

💡 You're a corporate or investor and looking for startups that are innovating in the same market as AI Medical Technology? We're happy to assist you with our Startup Sourcing service.